Current and Emerging Management Options for Clostridium Difficile Infection: What Is the Role of Fidaxomicin?

Clinical Microbiology and Infection - United Kingdom
doi 10.1111/1469-0691.12012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fidaxomicin for Clostridium Difficile-Associated Diarrhoea

Clinical Drug Investigation
MedicinePharmacology
2012English

Recurrent Clostridium Difficile Colitis in Elderly: The Role of Fidaxomicin

Clinical Management Issues
MedicineAccountingManagementBusiness
2014English

Current Status of Clostridium Difficile Infection

Nippon Daicho Komonbyo Gakkai Zasshi
2018English

Economic Evaluation of Fidaxomicin Compared With Vancomycin in the Treatment of Clostridium Difficile Infection

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Fidaxomicin Use and Clinical Outcomes for Clostridium Difficile–Associated Diarrhea

Infectious Diseases in Clinical Practice
Infectious DiseasesMicrobiology
2015English

The Difficile in Clostridium Difficile Infection

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2018English

Pin8 - Comparative Efficacy of Fidaxomicin, Vancomycin and Metronidazole for the Treatment of Clostridium Difficile Infection: A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clostridium Difficile Infection

Nature Reviews Disease Primers
Medicine
2016English

Clostridium Difficile Infection

Nature Reviews Disease Primers
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy